Intensive Care Unit-Acquired Weakness.

A. Nordon-Craft, PT, DSc, Department of Physical Therapy, School of Health Professions, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, MET 535, Fort Worth, TX 76107 (USA).
Physical Therapy (Impact Factor: 3.25). 01/2012; DOI: 10.2522/ptj.20110117
Source: PubMed

ABSTRACT Patients admitted to the intensive care unit (ICU) can develop a condition referred to as ICU-acquired weakness. This condition is characterized by profound weakness that is greater than might be expected to result from prolonged bed rest. ICU-acquired weakness often is accompanied by dysfunction of multiple organ systems. Individuals with ICU-acquired weakness typically have significant activity limitations often requiring physical assistance for even the most basic activities associated with bed mobility. Many of these individuals have activity limitations months to years after hospitalization. The purpose of this article is to review evidence that guides physical rehabilitation of people with ICU-acquired weakness. Included are diagnostic criteria, medical management, and prognostic indicators as well as criteria for beginning physical rehabilitation, with an emphasis on patient safety. Data are presented indicating that rehabilitation can be implemented with very few adverse effects. Evidence is provided for appropriate measurement approaches and for physical intervention strategies. Finally, some of the key issues are summarized that should be investigated to determine the best intervention guidelines for individuals with ICU-acquired weakness.


Available from: Margaret Schenkman, Jun 26, 2014
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Critical illness myopathy (CIM) and polyneuropathy (CIP) are common complications of critical illness that frequently occur together. Both cause so called intensive care unit (ICU)-acquired muscle weakness. This weakness of limb muscles increases morbidity and delay rehabilitation and recovery of walking ability. Although full recovery has been reported people with severe weakness may take months to improve walking. Focused physical rehabilitation of people with ICU-acquired muscle weakness is therefore of great importance. However, although physical rehabilitation is common, detailed knowledge about the pattern and the time course of recovery of walking function are not well understood. Therefore, the aim of the General Weakness Syndrome Therapy (GymNAST) study is to describe the time course of recovery of walking function and other activities of daily living in these patients.
    BMJ Open 10/2014; 4(10):e006168. DOI:10.1136/bmjopen-2014-006168 · 2.06 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Surviving critical illness is associated with persistent and severe physical, cognitive, and psychological morbidities. The Society of Critical Care Medicine has developed pain, agitation, and delirium guidelines and promoted mobility to improve care of critically ill patients. A task force has developed tools to facilitate and rapidly implement the translation of guideline care recommendations into practice. The Society of Critical Care Medicine has also assembled a task force to assess the long-term consequences of critical illness. This article will explore relationships between the pain, agitation, and delirium guidelines, mobility recommendations, and post-intensive care syndrome initiative. Implementation of the pain, agitation, and delirium guidelines taking into account current data regarding post-intensive care syndrome outcomes and potential interventions are an important first step toward improving outcomes for patients and their families. Research is needed to reduce the impact of long-term negative consequences of critical illness and to fully understand the best within- and post-ICU interventions, along with the optimal timing and dose of such interventions to produce the best long-term outcomes.
    Critical Care Medicine 09/2013; 41(9):S136-S145. DOI:10.1097/CCM.0b013e3182a24105 · 6.15 Impact Factor
  • Source
    Critical Care Medicine 09/2013; 41(9 (Suppl.)). DOI:10.1097/CCM.0b013e3182a240d5 · 6.15 Impact Factor